Danish pharma group Novo Nordisk has ... a connected inhaler device called Inspair that tracks and records breath actuations, an NFC-enabled add-on for prefilled syringes called Injay, and Datapen ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable ... Corporate Programme Vice President, Devices and Delivery Solutions, Novo Nordisk Steve Hoare, Quality, Regulatory Science ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Along with it, other form of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for patients across ... which are marketed primarily in the format of ...

In a move which could shake up the diabetes market, Novo Nordisk is ... delivery from pen devices is preferred by a huge majority of diabetics over vials injected with syringes, due to its ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.